- Home
- AMST vs SNSE Comparison
AMST vs SNSE Comparison
Compare AMST & SNSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMST
- SNSE
- Stock Information
- Founded
- AMST 2017
- SNSE 2005
- Country
- AMST United States
- SNSE United States
- Employees
- AMST N/A
- SNSE N/A
- Industry
- AMST Computer Software: Prepackaged Software
- SNSE Biotechnology: Pharmaceutical Preparations
- Sector
- AMST Technology
- SNSE Health Care
- Exchange
- AMST Nasdaq
- SNSE Nasdaq
- Market Cap
- AMST 13.3M
- SNSE 10.8M
- IPO Year
- AMST 2020
- SNSE 2021
- Fundamental
- Price
- AMST $2.88
- SNSE $8.68
- Analyst Decision
- AMST
- SNSE Strong Buy
- Analyst Count
- AMST 0
- SNSE 4
- Target Price
- AMST N/A
- SNSE $72.50
- AVG Volume (30 Days)
- AMST 40.5K
- SNSE 33.8K
- Earning Date
- AMST 09-29-2025
- SNSE 08-05-2025
- Dividend Yield
- AMST N/A
- SNSE N/A
- EPS Growth
- AMST N/A
- SNSE N/A
- EPS
- AMST N/A
- SNSE N/A
- Revenue
- AMST $82,544.00
- SNSE N/A
- Revenue This Year
- AMST N/A
- SNSE N/A
- Revenue Next Year
- AMST N/A
- SNSE N/A
- P/E Ratio
- AMST N/A
- SNSE N/A
- Revenue Growth
- AMST N/A
- SNSE N/A
- 52 Week Low
- AMST $2.00
- SNSE $5.00
- 52 Week High
- AMST $6.27
- SNSE $17.40
- Technical
- Relative Strength Index (RSI)
- AMST 46.22
- SNSE 57.34
- Support Level
- AMST $2.74
- SNSE $7.34
- Resistance Level
- AMST $2.94
- SNSE $8.23
- Average True Range (ATR)
- AMST 0.17
- SNSE 1.03
- MACD
- AMST -0.02
- SNSE 0.03
- Stochastic Oscillator
- AMST 35.51
- SNSE 50.48
About AMST Amesite Inc.
Amesite Inc is an artificial intelligence-driven platform and course designer that rapidly provides customized, high-performance and scalable online products for schools and businesses. The company helps educational institutions and businesses improve learning as their technology partner, delivering a disruptive technology driven by AI and offers a constellation of services that help partners implement new programs, and improve existing ones. Its customers are Enterprises, universities, and K-12 schools.
About SNSE Sensei Biotherapeutics Inc.
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).